Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.06 USD | +2.31% | +25.68% | +31.20% |
Jun. 24 | Replimune Group, Inc.(NasdaqGS:REPL) dropped from S&P Biotechnology Select Industry Index | CI |
Jun. 13 | Replimune Group Signs $100 Million PIPE Deal with Institutional Investors | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+31.20% | 664M | |
+25.83% | 46.56B | |
+45.38% | 41.67B | |
+0.69% | 41.16B | |
+30.52% | 32.4B | |
+22.30% | 28.18B | |
-6.35% | 28.1B | |
+49.25% | 14.52B | |
+49.18% | 13.74B | |
+3.45% | 12.17B |
- Stock Market
- Equities
- REPL Stock
- News Replimune Group, Inc.
- HC Wainwright Raises Price Target on Replimune Group to $51 From $50, Keeps Buy Rating